Zeventa Pharmaceutical Private Limited - Board Members
Founded in 2021 and headquartered in Gujarat, India.
2021 Rajkot, Gujarat (India) Inactive
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girdharlal Mohan Donga Appointed as Director since July 2021 | Director | 30-Jul-2021 | Current |
Hansaben Girdharbhai Donga Appointed as Director since July 2021 | Director | 30-Jul-2021 | Current |
Harsh Girdharbhai Donga Appointed as Director since July 2021 | Director | 30-Jul-2021 | Current |
Hirenbhai Tejabhai Sabhaya Appointed as Director since July 2021 | Director | 30-Jul-2021 | Current |
Khushboo Harsh Donga Appointed as Director since July 2021 | Director | 30-Jul-2021 | Current |
Manish Dineshbhai Saypariya Appointed as Director since July 2021 | Director | 30-Jul-2021 | Current |
Siddhi Birju Hapaliya Appointed as Director since July 2021 | Director | 30-Jul-2021 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Zeventa Pharmaceutical Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Zeventa Pharmaceutical Private Limited's leadership journey.
Loading...
Frequently Asked Questions
You can contact Zeventa Pharmaceutical Private Limited through their registered address at Plot No 1 To 10,Rs No 209/1,Balaji Ind. Estate,Kalawad Road, Chhapra,Tal Lodhika, Rajkot Gujarat, 360021, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Zeventa Pharmaceutical Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- GIRDHARLAL MOHAN DONGA
- KHUSHBOO HARSH DONGA
- SIDDHI BIRJU HAPALIYA
- MANISH DINESHBHAI SAYPARIYA
- HIRENBHAI TEJABHAI SABHAYA
- HARSH GIRDHARBHAI DONGA
- HANSABEN GIRDHARBHAI DONGA
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.